Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DA 1686 is a therapeutic antiarrhythmic compound.DA 1686 reduces the tachycardic effects of aconitine. It also reduces the effects of increased frequency of electrical stimulation and is 1.8 times more active than quinidine and 9 times more active than procainamide.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
25 mg | 6-8 weeks | $ 1,520.00 | |
50 mg | 6-8 weeks | $ 1,980.00 | |
100 mg | 6-8 weeks | $ 2,500.00 |
Description | DA 1686 is a therapeutic antiarrhythmic compound.DA 1686 reduces the tachycardic effects of aconitine. It also reduces the effects of increased frequency of electrical stimulation and is 1.8 times more active than quinidine and 9 times more active than procainamide. |
Synonyms | BRN 1029299, DA-1686, DA1686 |
Molecular Weight | 368.51 |
Formula | C23H32N2O2 |
CAS No. | 13071-27-7 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
DA 1686 13071-27-7 BRN 1029299 BRN1029299 DA-1686 BRN-1029299 DA1686 inhibitor inhibit